Seeking Alpha

Cameron (CAM)  - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA...

Cameron (CAM)  - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA reviewers say they won't OK the firm's defibrillator until it resolves problems of the battery depleting too quickly. The reviewers also say the product, which is inserted under the skin, may have more infection issues and work slower than similar devices placed in the heart.
From other sites
Comments (2)
  • 1980XLS-2.0
    , contributor
    Comments (525) | Send Message
    BSX to get in the Oil business?


    I never would have thought.
    23 Apr 2012, 11:02 AM Reply Like
  • Mobywhite
    , contributor
    Comments (413) | Send Message
    SA you might want to be a little more careful as I don't think Boston Scientific is buying CAM.
    23 Apr 2012, 07:36 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs